{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-040675","form_type":"8-K","ticker":"SRXH","cik":"0001471727","company_name":"SRx Health Solutions, Inc.","filed_at":"2023-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.163349+00:00","generated_at":"2026-06-08T03:24:58.306965+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Better Choice Q3 revenue rises 11% YoY to $13.1M; net loss improves 75%","bullets":["Revenue of $13.1M, up 11% YoY and 24% from Q2 2023; 75% from Halo Holistic product line.","Operating loss improved 59% YoY to $(2.6)M; operating margin improved 3,403 bps to (20%).","Net loss improved 75% YoY to $(1.6)M; EPS improved 77% to ($0.05) per share.","Adjusted EBITDA improved 95% YoY to $(0.1)M; Adjusted EBITDA margin improved 2,311 bps to (1%).","Newly appointed CEO Kent Cunningham highlighted organic digital growth and cost improvements."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-040675","json":"https://secwatch.observer/filing/0001493152-23-040675.json","markdown":"https://secwatch.observer/filing/0001493152-23-040675.md","text":"https://secwatch.observer/filing/0001493152-23-040675.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1471727/000149315223040675/0001493152-23-040675-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1471727/000149315223040675/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T03:24:58.306965+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1aba2f7b12495de6ac559be8f7df48d190d5dfca","claim":"SRx Health Solutions, Inc. reported nine months ended September 30, 2023 results: revenue $32.9 million, net income $(8.1) million, EPS ($0.26).","evidence_excerpt":"loss improved 46% YOY to $(8.1) million ● EPS improved 48% YOY to ($0.26) ● Adjusted EBITDA improved 47% YOY to $(3.8) million 1 ● Adjusted","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1471727/000149315223040675/0001493152-23-040675-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"nine months ended September 30, 2023"},{"label":"Revenue","value":"$32.9 million"},{"label":"Net income","value":"$(8.1) million"},{"label":"EPS","value":"($0.26)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e9b747f77ceb177d442777d62c5262816b5a79fe","claim":"SRx Health Solutions, Inc. reported third quarter ended September 30, 2023 results: revenue $13.1 million, net income $(1.6) million, EPS ($0.05).","evidence_excerpt":"Revenue increased 24% from second quarter 2023, and 11% year-over-year (“YOY”) to $13.1 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1471727/000149315223040675/0001493152-23-040675-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$13.1 million"},{"label":"Net income","value":"$(1.6) million"},{"label":"EPS","value":"($0.05)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}